secwatch.observer — SEC 8-K summary
======================================

Issuer:     KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
CIK:        0001877184
Form:       8-K
Filed at:   2026-07-14T20:08:33+00:00
Accession:  0001193125-26-303169
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 2.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kestra Medical reports Q4 revenue $28.6M (+66% YoY); secures $200M loan facility
--------------------------------------------------------------------------------

- Q4 FY2026 revenue $28.6M (+66% YoY); FY revenue $95.1M (+59% YoY); FY27 guidance $137M (+44%).
- Gross margin expanded to 54.8% in Q4 (vs 44.3% prior year); FY margin 51.4% (vs 40.5%).
- GAAP net loss Q4 $38.8M, FY $131.6M; adjusted EBITDA loss Q4 $26.7M, FY $87.0M.
- Entered $200M senior secured loan facility; drew $75M Tranche A on July 10, 2026; net proceeds ~$20M after repaying prior loan.
- Loan matures July 10, 2031; interest SOFR+5.50% (floor 3.25%); 48 months interest-only; minimum liquidity $20M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877184/000119312526303169/0001193125-26-303169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877184/000119312526303169/ck0001877184-20260710.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-303169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer